/tags/pharmaceutical-industry pharmaceutical industry en-US WLRN Tue, 19 Apr 2022 20:48:36 GMT /news/2022-04-19/why-cheap-older-drugs-that-might-treat-covid-never-get-out-of-the-lab The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients. Tue, 19 Apr 2022 20:48:36 GMT /news/2022-04-19/why-cheap-older-drugs-that-might-treat-covid-never-get-out-of-the-lab Arthur Allen - Kaiser Health News /news/npr-breaking-news/2021-11-23/3-of-americas-biggest-pharmacy-chains-have-been-found-liable-for-the-opioid-crisis Tuesday's verdict comes as CVS, Walgreens and Walmart face thousands of lawsuits filed by communities across the U.S. The companies say they did nothing wrong dispensing huge quantities of opioids. Tue, 23 Nov 2021 22:26:50 GMT /news/npr-breaking-news/2021-11-23/3-of-americas-biggest-pharmacy-chains-have-been-found-liable-for-the-opioid-crisis Brian Mann /2021-10-13/federal-judge-rejects-a-government-bid-to-delay-purdue-pharmas-bankruptcy-settlement Judge Colleen McMahon was expected to halt work on the controversial settlement that would give immunity from opioid lawsuits to the Sackler family. Instead she allowed work on the plan to go ahead. Thu, 14 Oct 2021 12:35:20 GMT /2021-10-13/federal-judge-rejects-a-government-bid-to-delay-purdue-pharmas-bankruptcy-settlement Brian Mann /news/npr-breaking-news/2021-09-28/the-purdue-pharma-deal-would-deliver-billions-but-individual-payouts-will-be-small People who were addicted to OxyContin or lost loved ones who were addicted to the drug expect very little in compensation from the multibillion-dollar Purdue Pharma bankruptcy settlement. Tue, 28 Sep 2021 12:28:00 GMT /news/npr-breaking-news/2021-09-28/the-purdue-pharma-deal-would-deliver-billions-but-individual-payouts-will-be-small Martha Bebinger /2021-09-16/the-doj-moves-to-block-the-purdue-pharma-bankruptcy-deal-that-shields-the-sacklers The DOJ is seeking to block implementation of any part of the Purdue Pharma bankruptcy deal until legal challenges are settled. The deal granted Sackler family members immunity from opioid lawsuits. Fri, 17 Sep 2021 11:05:38 GMT /2021-09-16/the-doj-moves-to-block-the-purdue-pharma-bankruptcy-deal-that-shields-the-sacklers Brian Mann /2021-08-31/purdue-pharma-scrambles-to-discourage-a-justice-department-appeal-of-bankruptcy-deal With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the DOJ. Tue, 31 Aug 2021 17:39:00 GMT /2021-08-31/purdue-pharma-scrambles-to-discourage-a-justice-department-appeal-of-bankruptcy-deal Brian Mann /news/2021-08-20/the-sacklers-want-immunity-from-the-opioid-crisis-for-a-long-list-of-their-associates In the Purdue Pharma bankruptcy trial now underway, scrutiny has focused on the Sacklers' demand for immunity from opioid lawsuits that would extend to a vast network of individuals and businesses. Fri, 20 Aug 2021 09:00:00 GMT /news/2021-08-20/the-sacklers-want-immunity-from-the-opioid-crisis-for-a-long-list-of-their-associates Brian Mann /2021-07-30/was-it-reasonable-to-ship-81-million-opioid-pills-to-this-small-west-virginia-city As a landmark federal opioid trial nears completion, West Virginia communities are demanding $2.5 billion in compensation. Drug firms say they acted responsibly in shipping millions of pills. Fri, 30 Jul 2021 16:36:56 GMT /2021-07-30/was-it-reasonable-to-ship-81-million-opioid-pills-to-this-small-west-virginia-city Brian Mann /2021-04-19/court-blasts-drugmaker-endo-for-trying-to-improperly-corrupt-opioid-trial A Tennessee court found Endo Pharmaceuticals liable for harm caused by its Opana ER opioid. The "harsh sanction" followed a court judgment that Endo made false statements and withheld key documents. Mon, 19 Apr 2021 09:05:00 GMT /2021-04-19/court-blasts-drugmaker-endo-for-trying-to-improperly-corrupt-opioid-trial Brian Mann /2021-03-28/as-u-s-corporations-face-reckoning-over-prescription-opioids-ceos-keep-cashing-in Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price. Sun, 28 Mar 2021 11:00:59 GMT /2021-03-28/as-u-s-corporations-face-reckoning-over-prescription-opioids-ceos-keep-cashing-in Brian Mann